Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BIOMARKER FOR USE IN DIAGNOSIS OF LUNG CANCER
Document Type and Number:
WIPO Patent Application WO/2016/013400
Kind Code:
A1
Abstract:
The present invention provides: a method for testing lung cancer, said method comprising detecting gelsolin and/or complement component C9 in an immune complex collected from a sample from a subject; and a kit for testing lung cancer, said kit containing an antibody capable of specifically recognizing gelsolin and/or an antibody capable of specifically recognizing complement component C9.

Inventors:
KURODA NAOTAKA (JP)
OHYAMA KANAME (JP)
NAKAMURA YOICHI (JP)
KOHNO SHIGERU (JP)
KISHIKAWA NAOYA (JP)
Application Number:
PCT/JP2015/069674
Publication Date:
January 28, 2016
Filing Date:
July 08, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV NAGASAKI (JP)
International Classes:
G01N33/68; G01N27/62; G01N33/48; G01N33/537; G01N33/574
Foreign References:
JP2009516178A2009-04-16
JP2010532480A2010-10-07
Other References:
YANG J ET AL.: "Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer", BMC CANCER, vol. 6, pages 203
ZHU WY ET AL.: "Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer", ANAT REC ( HOBOKEN, vol. 5, no. 2, 29 February 2012 (2012-02-29), pages 208 - 214
OKANO T ET AL.: "Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis", PROTEOMICS, vol. 6, no. 13, July 2006 (2006-07-01), pages 3938 - 3948, XP009140370
Attorney, Agent or Firm:
TAKASHIMA, HAJIME (JP)
Takashima 1 (JP)
Download PDF: